Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1979 2
1980 1
1981 1
1983 2
1985 2
1986 5
1987 2
1988 7
1989 5
1990 6
1991 3
1992 4
1993 2
1994 6
1995 5
1996 5
1997 5
1998 4
1999 2
2000 7
2001 4
2002 1
2004 4
2006 1
2007 1
2011 1
2013 1
2022 0
Text availability
Article attribute
Article type
Publication date

Search Results

89 results
Results by year
Filters applied: . Clear all
Page 1
Ribozyme-mediated cancer gene therapy.
Irie A, Bouffard DY, Scanlon KJ. Irie A, et al. Among authors: scanlon kj. Int J Urol. 1997 Jul;4(4):329-37. doi: 10.1111/j.1442-2042.1997.tb00203.x. Int J Urol. 1997. PMID: 9256319 Free article. Review. No abstract available.
The promised land.
Sobol RE, Scanlon KJ. Sobol RE, et al. Among authors: scanlon kj. Cancer Gene Ther. 2013 Dec;20(12):651. doi: 10.1038/cgt.2013.73. Cancer Gene Ther. 2013. PMID: 24346318 No abstract available.
Therapeutic applications of ribozymes.
Kijima H, Ishida H, Ohkawa T, Kashani-Sabet M, Scanlon KJ. Kijima H, et al. Among authors: scanlon kj. Pharmacol Ther. 1995;68(2):247-67. doi: 10.1016/0163-7258(95)02008-x. Pharmacol Ther. 1995. PMID: 8719970 Review.
Cisplatin resistance in human cancers.
Scanlon KJ, Kashani-Sabet M, Tone T, Funato T. Scanlon KJ, et al. Pharmacol Ther. 1991 Dec;52(3):385-406. doi: 10.1016/0163-7258(91)90033-i. Pharmacol Ther. 1991. PMID: 1820582 Review.
Anti-genes: siRNA, ribozymes and antisense.
Scanlon KJ. Scanlon KJ. Curr Pharm Biotechnol. 2004 Oct;5(5):415-20. doi: 10.2174/1389201043376689. Curr Pharm Biotechnol. 2004. PMID: 15544489 Review.
Commercializing medical technology.
Scanlon KJ, Lieberman MA. Scanlon KJ, et al. Cytotechnology. 2007 Apr;53(1-3):107-12. doi: 10.1007/s10616-007-9056-5. Epub 2007 Feb 28. Cytotechnology. 2007. PMID: 19003196 Free PMC article.
Oligonucleotides as modulators of cancer gene expression.
Curcio LD, Bouffard DY, Scanlon KJ. Curcio LD, et al. Among authors: scanlon kj. Pharmacol Ther. 1997;74(3):317-32. doi: 10.1016/s0163-7258(97)00005-3. Pharmacol Ther. 1997. PMID: 9352587 Review.
Oligonucleotide modulation of multidrug resistance.
Bouffard DY, Ohkawa T, Kijima H, Irie A, Suzuki T, Curcio LD, Holm PS, Sassani A, Scanlon KJ. Bouffard DY, et al. Among authors: scanlon kj. Eur J Cancer. 1996 Jun;32A(6):1010-8. doi: 10.1016/0959-8049(96)00065-2. Eur J Cancer. 1996. PMID: 8763342 Review. No abstract available.
89 results